Alert: Rating Downgrade (1/12/24)-Sarepta Therapeutics Inc (NASDAQ: SRPT).
Stock Rating Downgrade The Value Trend Rating for Sarepta Therapeutics Inc (NASDAQ: SRPT) weakened of late from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in […]